The study indicated that NAFLD and higher ALT levels were risk factors for fasting insulin and C-peptide, but not for fasting glucose, suggesting a potential direct influence of fatty liver on elevated insulin levels and an indirect effect on blood sugar through insulin and various metabolic markers. The gene discussed is INS; the disease is Hepatic steatosis.